Dow Up1.58% Nasdaq Up1.29%

Vanda Pharmaceuticals, Inc. (VNDA)

-NGM
7.91 Down 0.03(0.38%) 2:20PM EST - Nasdaq Real Time Price
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
Net Income 20,186   (21,055) (28,617)
Operating Activities, Cash Flows Provided By or Used In
Depreciation2,958  2,082  2,688  
Adjustments To Net Income(71,738)5,404  6,873  
Changes In Accounts Receivables(1,623)(863)450  
Changes In Liabilities(28,809)(26,424)(25,427)
Changes In Inventories(2,210) -   -  
Changes In Other Operating Activities(318)1,264  (884)
Total Cash Flow From Operating Activities (81,554) (39,592) (44,917)
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(769)(176)(2,017)
Investments(3,513)(34,099)47,771  
Other Cash flows from Investing Activities(7,755) -   -  
Total Cash Flows From Investing Activities (12,037) (34,275) 45,754  
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -   -  
Sale Purchase of Stock90,164  50,055  12  
Net Borrowings -   -   -  
Other Cash Flows from Financing Activities(436)(196) -  
Total Cash Flows From Financing Activities 89,728   49,859   12  
Effect Of Exchange Rate Changes -   -   -  
Change In Cash and Cash Equivalents (3,863) (24,008) 849  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.